Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bio-Techne Corp (TECH) had Stock-Based Compensation of $40.83M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$316.96M |
|
$-17.68M |
|
$118.15M |
|
$198.81M |
|
$340.82M |
|
$-23.86M |
|
$1.00M |
|
$-22.86M |
|
$-22.86M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-23.86M |
|
-- |
|
154.91M |
|
155.76M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$608.30M |
|
$245.72M |
|
$1.95B |
|
$2.56B |
|
$175.85M |
|
$346.00M |
|
$463.21M |
|
$639.06M |
|
-- |
|
$572.27M |
|
$1.92B |
|
-- |
|
| Cash Flow Statement Financials | |
$287.56M |
|
$-35.18M |
|
$-253.91M |
|
$151.79M |
|
$162.19M |
|
$10.39M |
|
|
Stock-Based Compensation |
$40.83M |
$-50.39M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|